H.C. Wainwright Sticks to Their Buy Rating for Global Blood Therapeutics (GBT)

In a report released today, Debjit Chattopadhyay from H.C. Wainwright maintained a Buy rating on Global Blood Therapeutics (NASDAQ: GBT), with a price target of $125. The company’s shares closed yesterday at More »

Oppenheimer Keeps Their Buy Rating on Paypal Holdings (PYPL)

In a report released today, Glenn Greene from Oppenheimer reiterated a Buy rating on Paypal Holdings (NASDAQ: PYPL), with a price target of $95. The company’s shares closed yesterday at $77.48. Greene More »